Company Filing History:
2 out of 30 
1 out of 15 
1 out of 1 Years Active: 2014-2021
Title: Antonio García García: Innovator in Neuropathic Pain Treatment
Introduction
Antonio García García is a notable inventor based in Alpedrete, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuropathic pain. His innovative approach has led to the development of a unique compound that addresses this challenging medical condition.
Latest Patents
García García holds a patent for "Sulphated disaccharides for the treatment of neuropathic pain." This invention relates to sulphated disaccharides of formula (I) that are effective in treating neuropathic pain. The pharmaceutical composition includes the compound of formula (I) along with at least one pharmaceutically acceptable excipient. The compounds have shown effectiveness in various experimental models of neuropathic pain, making them a promising option for treating conditions such as mechanical allodynia and cold allodynia. He has 1 patent to his name.
Career Highlights
Throughout his career, Antonio García García has worked with reputable organizations, including Bioberica, S.A.U. and Universidad Autónoma de Madrid. His experience in these institutions has allowed him to refine his research and contribute to advancements in medical treatments.
Collaborations
García García has collaborated with esteemed colleagues such as Josep Vergés Milano and Eulàlia Montell Bonaventura. These partnerships have enriched his research and expanded the impact of his work in the field of neuropathic pain treatment.
Conclusion
Antonio García García is a pioneering inventor whose work in developing sulphated disaccharides for neuropathic pain treatment showcases his commitment to improving patient care. His contributions to the pharmaceutical industry are noteworthy and continue to influence the treatment landscape for neuropathic pain.